Effect of All-Trans-Retinoic Acid on the Development of Chronic Hypoxia-Induced Pulmonary Hypertension-Reference-Cited by-同舟云学术

Effect of All-Trans-Retinoic Acid on the Development of Chronic Hypoxia-Induced Pulmonary Hypertension

Published:2010 Issue:8 Volume:74 Page:1696-1703
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Zhang Erquan¹,Jiang Baohua¹,Yokochi Ayumu¹,Maruyama Junko¹,Mitani Yoshihide¹,Ma Ning¹,Maruyama Kazuo¹

Affiliation:

1. Anesthesiology and Critical Care Medicine, Physiology, Pediatrics, Mie University School of Medicine, Tsu and Faculty of Health Science, Suzuka University of Medical Science

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/74/8/74_CJ-10-0097/_pdf

Reference37 articles.

1. Pulmonary Arterial Hypertension

2. 2. Mitani Y, Maruyama K, Sakurai M. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 1997; 96: 689-697.

3. 3. Roberts JD, Roberts CT, Jones RC, Zapol WM, Bloch KD. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res 1995; 76: 215-222.

4. 4. Maruyama J, Maruyama K, Mitani Y, Kitabatake M, Yamauchi T, Miyasaka K. Continuous low-dose NO inhalation does not prevent monocrotaline-induced pulmonary hypertension in rats. Am J Physiol 1997; 272: H517-H524.

5. 5. Ilkiw R, Todorovich-Hunter L, Maruyama K, Shin J, Rabinovitch M. SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats. Circ Res 1989; 64: 814-825.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension;BMC Pulmonary Medicine;2022-03-05

2. A wrinkle in time: circadian biology in pulmonary vascular health and disease;American Journal of Physiology-Lung Cellular and Molecular Physiology;2022-01-01

3. Myeloid-Derived Suppressor Cells and Pulmonary Hypertension;International Journal of Molecular Sciences;2018-08-03

4. Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats;Journal of Anesthesia;2015-05-01

5. Sp1 modification of human endothelial nitric oxide synthase promoter increases the hypoxia-stimulated activity;Microvascular Research;2014-05